Sweden· SE-20080703000105
Blopress Comp 32 mg/25 mg Tablett
A medicinal product containing hydrochlorothiazide + candesartan cilexetil, registered in Sweden by Cheplapharm Arzneimittel GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Hydrochlorothiazide + Candesartan Cilexetil
- Manufacturer
- Cheplapharm Arzneimittel GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20080703000105
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrochlorothiazide + candesartan cilexetil in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCANCOMBINOKrka, d.d., Novo mesto, Novo mesto
- FinlandArtican CompTEVA Sweden AB
- GermanyAtacand PlusCheplapharm Arzneimittel Gmbh
- ItalyBLOPRESIDCHEPLAPHARM ARZNEIMITTEL GMBH
- FranceCANDESARTAN/HYDROCHLOROTHIAZIDE ARROW 16 mg/12,5 mg, compriméARROW GENERIQUES
- CanadaATACAND PLUSCHEPLAPHARM ARZNEIMITTEL GMBH
- United StatesATACAND HCTANI Pharmaceuticals, Inc.
- NorwayAtacand PlusOrifarm AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Atacand Plus, Atacand Plus Mite
- Belgium · Atacand Plus, Candesartan Plus Hct Eg
- Bulgaria · Кандесартан Hct Актавис, Кандестар Н
- Cyprus · Atacand Plus, Candepress Comp
- Czechia · Cancombino, Carzap Hct
- Germany · Atacand Plus, Atacand Plus Forte
- Denmark · Atacand Zid, Candemox Comp
- Estonia · Atacand Plus, Canocombi
- Spain · Atacand Plus, Atacand Plus Forte
- Finland · Atacand Plus, Candemox Comp
- France · Candesartan/Hydrochlorothiazide Arrow, Candesartan/Hydrochlorothiazide Arrow Lab
- United Kingdom (Northern Ireland) · Candesartan And Hydrochlorothiazide, Candesartan/Hydrochlorothiazide
- Greece · Atacand Plus, Fyronexe Plus®
- Croatia · Karbicombi
- Hungary · Karbicombi
- Ireland · Atacand Plus, Blopress Plus
- Iceland · Candesartan Hct Beta, Candpress Comp
- Italy · Blopresid, Candesartan E Idroclorotiazide Alter
- Lithuania · Candesartan Hct Actavis, Canocombi
- Luxembourg · Atacand Plus, Candesartan Comp Ratiopharm
- Latvia · Canocombi, Carzan Hct
- Malta · Candesartan/Hydrochlorothiazide Aurobindo Pharma (Malta)
- Netherlands · Atacand Plus, Candesartan Cilexetil Hctz Krka
- Norway · Atacand Plus, Atacand Plus Mite
- Poland · Candepres Hct, Carzap Hct
- Portugal · Blopress, Candesartan + Hidroclorotiazida Alter
- Romania · Candesartan Hct Swyssi, Candesartan Hidroclorotiazidă Aurobindo
- Slovenia · Atacand Plus, Candea Hct
- Slovakia · Atacand Plus, Candesartan Hct Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d728cea-9a61-46bf-a476-771e54116630 GET /v1/drugs/1d728cea-9a61-46bf-a476-771e54116630?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR",
"SmPC",
"PL"
],
"se_npl_id": "20080703000105",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20080703000105",
"product_doc_link": "https://docetp.mpa.se/LMF/Blopress%20Comp%20tablet%20ENG%20SmPC_09001bee807a18e3.pdf"
}See everything about hydrochlorothiazide + candesartan cilexetil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.